European Forum for Industrial Biotechnology 2009 – Interview with Steen Riisgaard, CEO Novozymes

24.07.2009

European Forum for Industrial Biotechnology 2009 – Interview with Steen Riisgaard, CEO Novozymes

Last week, the organizers of the European Forum for Industrial Biotechnology 2009 (EFIB 2009) sat down with Novozymes CEO, and EFIB Advisory Board Member, Steen Riisgaard to capture his impression of EFIB 2009. 

 

Why is it important for companies to attend EFIB 2009? 

It is too easy to become focused on the day-to-day  details of running a business; EFIB offers companies the chance to address the larger issues that are facing our industry.  EFIB 2008 was an invaluable opportunity to gather together with other stakeholders determined to bring about the biobased economy.  At that conference, we were able to pin-point the dramatic impact that the reliable supply of feedstock has in realising the bio-based economy. This kind of breakthrough can only come about with a wide gathering that includes the end users of bioproducts, biotechnology companies, policy-makers, research organisations and academics. I am sure that this year’s conference will deliver similarly important results.   

Tags: 

Latest Position papers